Sort
40,608 grants matching “prostate cancer”
In vivo effects of sulforaphane supplementation on normal human prostate
$536,166Daniel W Lin · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
$536,161Srinivas Raghavan Viswanathan · Dana-Farber Cancer Inst · U01 · FY2025 · CA
Rad-pathomic deep learning models to assist radiologists in differentiating aggressive from indolent prostate cancer on MRI
$536,074Mirabela Rusu · Stanford University · R37 · FY2023 · CA
OKLAHOMA CCOP
$536,040Warren Cancer Research Foundation · U10 · FY2002 · CA
Trans-urethral ultrasound for prostate cancer therapy
$535,980Brian J Davis · Mayo Clinic Rochester · R33 · FY2006 · CA
Characterizing Prostate Cancer By ex vivo MRS Signatures
$535,894Leo L Cheng · Massachusetts General Hospital · R01 · FY2009 · CA
Development of Novel Targeted Therapeutic Agents for Castration Resistant Prostate Cancer
$535,890Adegboyega Oyelere · Georgia Institute Of Technology · R01 · FY2024 · CA
Early Detection of Cancer By Affinity Mass Spectrometry
$535,858Oliver John Semmes · Eastern Virginia Medical School · U01 · FY2007 · CA
Preventing invasive prostate cancer
$535,783Raymond C Bergan · University Of Nebraska Medical Center · R01 · FY2023 · CA
Transcription Dynamics in Single Cells
$535,701Daniel Larson · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Estimating Overdiagnosis in Cancer Screening Studies
$535,700Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Characterization of human antibodies to sialyl-Lewis A (sLeA) derived from patien
$535,666Philip O. Livingston · Mabvax Therapeutics, Inc. · R42 · FY2010 · CA
Local Therapy of Gliomas Using a Novel BCNU Formulation
$535,608Direct Therapeutics, Inc. · R44 · FY2004 · CA
ABERRANTLY UPREGULATED P-REX1 PROMOTES CASTRATION-RESISTANT PROSTATE CANCER PROGRESSION
$535,599Creighton University · · FY2013 · Department of Defense
Varicella virus antigens in glioma etiology and survival
$535,578Joseph Leo Wiemels · University Of California, San Francisco · U01 · FY2014 · CA
A Combination Therapy to Treat Cancer-Related Fatigue
$535,442Sriram Yennu · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
A new and non-autonomous role of androgen signaling in prostate tumorigenesis
$535,334Zijie Sun · Albert Einstein College Of Medicine · R01 · FY2025 · CA
Systemic RNA Delivery to Tumors
$535,205Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2022 · CA
Colorectal Neoplasia in SELECT Participants
$535,169M. Peter Lance · University Of Arizona · R01 · FY2008 · CA
A Sustainable Approach to Increasing Cancer Screening in Community Health Centers
$535,151Karen M Emmons · Dana-Farber Cancer Inst · R01 · FY2011 · CA
Core C: Pathology, Biospecimen and Immune Profiling
$535,098Tamara Levin Lotan · University Of Southern California · U19 · FY2021 · CA
NEUROD1 function in SCLC fate and plasticity
$535,073Trudy Gale Oliver · Duke University · R01 · FY2025 · CA
EXERCISING TOGETHER: A randomized controlled trial of partnered exercise training on the health of couples coping with cancer
$535,059Kerri M Winters-Stone · Oregon Health & Science University · R01 · FY2022 · CA
Getting More from Less: Multi-omic Capture and Analysis from Patient Samples
$535,014Scott M Berry · Salus Discovery, Llc · R44 · FY2017 · GM
Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility
$535,008Ross Lake · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA